Literature DB >> 775699

Herpes simplex keratitis and keratoconus in the atopic patient. A clinical and immunological study.

D Easty, C Entwistle, A Funk, J Witcher.   

Abstract

Selected case histories indicate that there is good evidence that atopic disease is associated with severe primary and recurrent ocular herpes. The salient features of the syndrome are that the disease is often bilateral, that recurrences are more frequent, and that the corneal epithelium is often slow to regenerate after disease. Therapeutic difficulties may be encountered because atopic eye disease requires anti-inflammatory therapy which is contraindicated in epithelial herpes. Keratoplasty in herpetic disease in the presence of vascularization or atopic eye disease should be avoided, as an augmented homograft reaction is also an occasional complication. Screening of patients for serum immunoglobulins and cellular immunity using in vitro lymphocyte transformation and macrophage migration inhibition tests, failed to reveal any group evidence of immune deficit, but there was evidence of this in some individuals. The most serious management problems occurred in the presence of raised IgE levels. In a group of patients with keratoconus, IgE was raised in 17 per cent, and there was a depression of IgA in 8 per cent. A knowledge of the serum innumoglobulin levels can be of help in the management of the keratoconus patient in the postoperative period after keratoplasty.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 775699

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  16 in total

1.  Severing corneal nerves in one eye induces sympathetic loss of immune privilege and promotes rejection of future corneal allografts placed in either eye.

Authors:  K J Paunicka; J Mellon; D Robertson; M Petroll; J R Brown; J Y Niederkorn
Journal:  Am J Transplant       Date:  2015-04-14       Impact factor: 8.086

2.  Incidence of keratoconus in spring catarrh.

Authors:  M D Khan; N Kundi; N Saeed; A Gulab; A F Nazeer
Journal:  Br J Ophthalmol       Date:  1988-01       Impact factor: 4.638

3.  Immunoglobulin patterns in keratoconus with particular reference to total and specific IgE levels.

Authors:  E G Kemp; C J Lewis
Journal:  Br J Ophthalmol       Date:  1982-11       Impact factor: 4.638

4.  Keratoconus and coexisting atopic disease.

Authors:  A Rahi; P Davies; M Ruben; D Lobascher; J Menon
Journal:  Br J Ophthalmol       Date:  1977-12       Impact factor: 4.638

5.  Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly.

Authors:  Erminia Ridolo; P Kihlgren; I Pellicelli; M C Nizi; F Pucciarini; C Incorvaia
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

6.  Allergic conjunctivitis renders CD4(+) T cells resistant to t regulatory cells and exacerbates corneal allograft rejection.

Authors:  N J Reyes; P W Chen; J Y Niederkorn
Journal:  Am J Transplant       Date:  2013-03-13       Impact factor: 8.086

Review 7.  New twists to an old story: novel concepts in the pathogenesis of allergic eye disease.

Authors:  Daniel R Saban; Virginia Calder; Chuan-Hui Kuo; Nancy J Reyes; Darlene A Dartt; Santa J Ono; Jerry Y Niederkorn
Journal:  Curr Eye Res       Date:  2013-01-02       Impact factor: 2.424

8.  Bilateral herpetic keratitis.

Authors:  K R Wilhelmus; M G Falcon; B R Jones
Journal:  Br J Ophthalmol       Date:  1981-06       Impact factor: 4.638

Review 9.  Therapeutic options in ocular allergic disease.

Authors:  M Hingorani; S Lightman
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 10.  [Ocular involvement in atopic dermatitis : Clinical aspects and therapy].

Authors:  P Maier; T Lapp; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.